|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
|
|---|---|---|---|---|---|---|---|
| Current assets | |||||||
| Cash and cash equivalents | |||||||
| Prepaid expenses | |||||||
| Total current assets | |||||||
| Long-term prepaid expenses | |||||||
| Deferred offering costs | |||||||
| Investments held in Trust Account | |||||||
| Total Assets | |||||||
| Current liabilities | |||||||
| Accrued expenses | |||||||
| Due to officer | |||||||
| Accrued offering costs | |||||||
| Promissory note — related party | |||||||
| Total current liabilities | |||||||
| Deferred underwriting fee | |||||||
| Total Liabilities | |||||||
| Class A Ordinary Shares subject to possible redemption, 17,250,000 shares issued and outstanding at redemption value of approximately $10.69 and $10.51 per share as of June 30, 2026 and December 31, 2025, respectively | |||||||
| Shareholders’ Deficit | |||||||
| Ordinary shares, Value | |||||||
| Class A Ordinary Shares | |||||||
| Class B Ordinary Shares | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total Shareholders’ Deficit | |||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
Loading...